4//SEC Filing
MEDNAX, INC. 4
Accession 0001209191-17-037286
$MDCIK 0000893949operating
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:37 PM ET
Size
8.3 KB
Accession
0001209191-17-037286
Insider Transaction Report
Form 4
CALABRO JOSEPH M
President and COO
Transactions
- Award
Common Stock
2017-06-01+67,398→ 296,379 total - Sale
Common Stock
2017-06-01$55.00/sh−23,327$1,282,934→ 262,784 total
Footnotes (4)
- [F1]Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 16,849 additional shares based on the achievement of certain performance-based criteria for the period from April 1, 2017 through March 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.
- [F2]Sales made pursuant to Reporting Person's 10b5-1 trading plan.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in sixty-four (64) separate transactions with prices ranging from $54.13 to $55.40 for an average weighted sales price of $54.9978. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Reflects a reduction of 10,268 in previously reported target restricted shares that were granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with achievement of specified performance-based criteria below target for the performance period from April 1, 2016 through March 31, 2017. The decrease in restricted shares impacts the installments vesting on June 1, 2017, June 1, 2018 and June 1, 2019. The vesting of such shares remains subject to continued employment.
Documents
Issuer
MEDNAX, INC.
CIK 0000893949
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0000893949
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:37 PM ET
- Size
- 8.3 KB